Researchers still found 'excellent' survival rates for both primary, secondary disease
by scrubba on Mon Dec 26, 2011 07:49 AM
I have had three rounds of R-chop to treat my B-cell NHL ... the treatment has gone well and I am scheduled to have a Pet scan in a few days. If there are no signs of cancer, I am not sure if I should continue with the next three scheduled rounds of chemo. Has anyone discontinued their chemotherapy midstream and does anyone have any recommendations based on their experience?.... Thanks for reading.
by crayfish on Mon Dec 26, 2011 12:18 PM
My husband had a different cancer but we were in a similar situation. He had a clean PET after 3 of 6 but he continued on in the spirit of "making sure". This is what our wonderful oncologist planned and wanted and he was the man. PETs and CTs don't always read in black and white but mostly we didn't trust the *&%^%$ cancer. Mike was really sick going into the last one and the doctor told him he could stop but he wanted to finish the course. We kind of related it to taking antibiotics - you got to take all the pills even if you're feeling better. He got a lighter dose, they kept a close eye on him and he got through it.
I really didn't have a say but was in agreement. I've been coming to this site for a year and a half and read all the posts. Something I picked up on and would like to relate is - how horrible would it be if you stopped the chemo and then had a recurrence? It happens.
So that's our experience and some of my thoughts.
God bless you in your fight -
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
Do you use smart phone apps?
Take our short survey on hospital smart phone apps.
We care about your feedback. Let us know how we can improve your CancerCompass experience.